ST
SkyWater Technology, Inc (SKYT)·Q3 2025 Earnings Summary
Executive Summary
- Q3 2025 was a record revenue quarter at $150.7M, with GAAP gross margin 24.0% and Non-GAAP gross margin 24.6%; Non-GAAP diluted EPS was $0.24 while GAAP diluted EPS was $2.95, the latter inflated by a preliminary $110.8M bargain purchase gain and a $27.5M tax valuation allowance release .
- Results meaningfully beat Wall Street consensus: revenue $150.7M vs $135.4M estimate*, EPS $0.24 vs -$0.17 estimate*, and EBITDA outperformed ($25.8M adj. vs $11.45M estimate*), driven by stronger-than-expected Texas (Fab 25) wafer services and ATS timing pull-ins .
- Q4 2025 guidance raised on profitability: total revenue $155–$165M, Non-GAAP GM% 17–20% (up from prior 12–15%), adjusted EBITDA $16–$22M; tools revenue trimmed to $17–$18M and OpEx reset higher at $23–$24M .
- Strategic catalysts: four new quantum customer engagements (including SQC and QuamCore), record quantum ATS revenues, and better-than-expected contribution from Texas strengthening confidence in the 2026 baseline of at least $600M revenue and $60M adjusted EBITDA .
What Went Well and What Went Wrong
What Went Well
- Record consolidated revenue ($150.7M) with Texas wafer services contributing ~$86.6M; Non-GAAP gross margin improved 230 bps YoY to 24.6% and adjusted EBITDA reached $25.8M (17.1% margin) .
- Quantum momentum: “We have signed four new quantum customers since the second quarter…on track to exceed 30% growth in our ATS revenues from quantum customers in fiscal 2025” — CEO Thomas Sonderman .
- Texas (Fab 25) upside: “Texas operations contributed nearly $87 million of wafer services revenue… revenue upside flowed directly to gross profit” — CEO; CFO quantified recurring gross profit uplift and elements of one-time Q3 cost favorability .
What Went Wrong
- Legacy tools revenue remained weak YoY ($3.7M vs $30.7M), continuing to weigh on mix; Legacy SkyWater total revenue down 32% YoY to $64.1M .
- A&D ATS demand uncertainty: ~$4M pulled forward into Q3 and guidance reflects a sequential decline in ATS due to government funding delays/shutdown dynamics .
- OpEx run-rate higher than previously modeled ($23–$24M/quarter) reflecting scale post-acquisition; potential inflation-related $5M tools overrun risk in Q4 if funding not secured .
Financial Results
Segment revenue breakdown
KPIs
Drivers and adjustments (context)
- GAAP net income benefited from a preliminary $110.8M bargain purchase gain (Fab 25) and a $27.5M non‑cash DTA valuation allowance release; additional $4.3M tax benefit tied to post‑acquisition deferred tax assets .
- CFO noted ~$12M of one‑time Q3 gross profit positives (near 100% margin revenue items; warranty accrual reversal due to higher yields; STI accrual reversal; lower-than-expected tariff exposure), plus ~$8M of recurring gross profit uplift expected to carry into Q4, then normalize to ~$5M/quarter .
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Record Q3 revenues of nearly $151 million… majority of the upside was related to purchase accounting for FAB25’s revenue in Texas and ATS revenues… above the high end of our expectations at over $54 million.” — Thomas Sonderman, CEO .
- “Texas operations contributed nearly $87 million… while we expect wafer services volumes in Texas will normalize… ongoing financial contribution from FAB25 is more favorable than we originally forecast.” — Thomas Sonderman .
- “We have signed four new quantum customer engagements since Q2… positioning SkyWater to exceed 30% revenue growth with our quantum customers in fiscal 2025.” — Thomas Sonderman .
- “Approximately $8 million of [gross profit] benefit to continue into the fourth quarter, after which we expect Texas WIP levels to normalize, resulting in a net ongoing gross profit upside from Texas of approximately $5 million per quarter… roughly $12 million reflects pure profit revenue upside and ~ $5 million of non-recurring cost savings.” — Steve Manko, CFO .
Q&A Highlights
- Gross margin sustainability: CFO detailed Q3 one-time positives (near-100% margin revenue items, warranty accrual reversal, STI accrual reversal, lower tariff exposure) and updated FY26 margin outlook to “mid to upper teens” Non-GAAP .
- Quantum pipeline: Management reiterated >30% FY25 quantum ATS growth and similar pace in 2026, with breadth across modalities (spin, superconducting, photonic, ion trap) and advantages from coupling front-end and advanced packaging .
- Fab 25 performance/normalization: Better-than-expected initial quarter driven by elevated WIP and purchase accounting; visibility to low‑$80M/quarter wafer services run‑rate and recurring gross profit uplift .
- A&D environment: Continued funding delays; some program acceleration pulled into Q3; management emphasized structural demand (DoD adoption of foundry model, drone-based systems) and platform progress (ThermaVue, RadHard, AP) .
- Q4 tools risk: Potential net loss on tools (~$5M) if incremental funding not secured, not embedded in guidance ranges .
Estimates Context
Q3 2025 actuals vs consensus
Q4 2025 guidance vs consensus
*Values retrieved from S&P Global.
Key Takeaways for Investors
- Strong multi-faceted beat: Revenue, EPS, and EBITDA all materially exceeded consensus, powered by Texas wafer services and ATS timing; near-term margin uplift is partly one-time, but recurring TX gross profit supports Q4 and sets a better baseline for 2026 .
- Guidance reset: Gross margin raised to 17–20% Non-GAAP for Q4 (from 12–15% previously), with adjusted EBITDA guided up to $16–$22M; tools revenue lowered and OpEx reset higher, reflecting scale post-acquisition .
- Structural drivers: Quantum engagements (SQC, QuamCore) and advanced packaging ramp underpin ATS growth; TX Fab 25 expands scale and domestic positioning amid tariff and onshoring tailwinds .
- Watch near-term risks: A&D ATS timing remains sensitive to Washington funding cycles; tools revenue variability and potential Q4 tools charge (~$5M) could add volatility .
- 2026 baseline looks conservative: Management reaffirmed confidence in at least $600M revenue and $60M adjusted EBITDA for 2026, with TX normalization and ATS momentum providing visibility .
- Trading implications: Positive surprise on profitability and raised margin outlook are likely stock catalysts; monitor Q4 execution against raised GM%/EBITDA and clarity on tools funding to gauge durability of margin expansion .
- Longer-term thesis: SkyWater’s trusted U.S. foundry model at foundational nodes, expanding advanced packaging, and quantum ecosystem positioning create differentiated exposure to domestic semis infrastructure and defense demand .
Additional Notes and Cross-References
- Q4 outlook details (ranges for ATS, wafer services, tools, margins, OpEx, EPS) published in the Q3 2025 8‑K/press release .
- Balance sheet step-up (PP&E, debt) and cash: total debt increased to fund Fab 25; cash at quarter-end $30.9M .
- Historical revision: accumulated deficit reduced by $1.970M due to immaterial ATS revenue overstatements in 2022–2023 .